Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more Has the pandemic made the opioid epidemic worse? In interviews with HealthDayContinue Reading

FRIDAY, Oct. 1, 2021 (HealthDay News) — The COVID-19 pandemic has shaken up the U.S. opioid crisis in ways bad and good, increasing the risk of use and overdose but also spurring innovative approaches to treatment. The pandemic has definitely been linked to an increase in opioid use and overdoseContinue Reading